5 ms·
It's a concise article, and yet tl;dr ... > The simple answer is because they can. > Rather than lower prices, rules for Medicare help raise them. ... And it
by mirimir 10y ago
It's a concise article, and yet tl;dr ...
> The simple answer is because they can.
> Rather than lower prices, rules for Medicare help raise them. ... And it is illegal for Medicare to negotiate with drug companies.
> But [negotiating] would be effective only if the government could also refuse to pay for some medicines, ...
The spectre of so-called government “death panels” looms large.
- gonzo41 10y ago> The simple answer is because they can. Americans social contract is more about money than about their fellow man. Case in point, Epi-pen, assumed actual cost $30, sale price $600. They would still be doing great if they only cost $50.
- mirimir 10y agoYes, it's about money. Monetization of intellectual property. Whether it's entertainment, software, drugs or medical devices. Regarding EpiPen, epinephrine has been generic for many decades, but the device is still protected by patent.
- throwaway049 10y agoIn the USA, if I have a potentially fatal medical problem and I can't pay for treatment (myself or via insurance) what are my options? I ask because I imagine I could not get treated which is the same outcome as 'death panels' but without the government bureaucracy.
- mirimir 10y agoThat's an excellent point. You wouldn't get treated.
- mirimir 10y agoUpon reflection, it's just that you probably wouldn't get adequately treated. And if you managed to get adequately treated, you'd probably go bankrupt.
- omegaham 10y agoIt ends up being a really terrible game. You get treated, and then you get presented with an outrageously high bill. You then have two options - negotiate with the billing company, or go bankrupt. A large number of people take the latter[1]. The result is that the hospital then has to eat the costs of the procedure... which it then responds to by jacking up the price even further for everyone else, knowing full well that most of the uninsured patients who get the even higher price won't be able to pay that, either. The hospitals then use this increased price to negotiate better rates with the insurance companies. So, you do get the treatment you need, but it nukes your finances, and everyone else ends up paying for it anyway in this ad-hoc, incoherent, uncoordinated mess. [1]http://www.cnbc.com/id/100840148 http://www.cnbc.com/id/100840148
- pnutjam 10y agoWell, you get the most basic treatment. If you are dying quickly, you can get treated. If you have a longer term issue or re-occuring issue, good luck. Hospitals don't have to treat everyone, they are legally able to stabilize you and let you die from complications. More often, you slowly degrade due to lack of treatment. Then you can't work and end up on medicaid and get the treatments you need. However, now your disabled. It's a great system.
- deleted 10y ago[deleted]
- refurb 10y agoThere are plenty of charitable hospitals in the US that will treat people who have no other options.
- ekianjo 10y agohow about travelling out of the US, get treatment where it's cheaper, and come back when you are better?
- antisthenes 10y agoMedical tourism, bankruptcy or dying.
- Coding_Cat 10y agoWhat is to stop the Government from saying "we will buy this medicine at X$", where X is a fair price they could negotiate. And if negotiations fail just go "right, you are taking X$, or we are taking your patent in the name of public intrest". I know this is a big no-no in American culture (and other parts of the world), but it is close to what say India and China are doing by ignoring patents on medicine that is needed but not affordable. To me, this is a much preferable solution to "death panels". Some would argue that, for economic reasons, this would lead to less research or pharmaceuticals pulling out of the US market. But history has shown the opposite to be true. Again look at China and some of the heavy restrictions it puts on foreign companies there. Do they hurt their bottom-line compared to the 'American approach'? probably. Do they still turn a profit despite them? yes. And that's why many companies still try to get into the Chinese market. profit is profit and as long as they can get some, even if it's pennies, they'll stay in a market. Let's also not forget that profits in the pharmaceutical industry are insanely high, even when taking into account the cost of research.
- mirimir 10y agoThe cost of research is far lower than claimed. Tufts Center for the Study of Drug Development is heavily influenced by the pharmaceutical industry. Their estimates of drug development costs are arguably inflated. Or at least, they don't question the industry's creative accounting methods. In reality, it's arguably promotion and advertising that take the biggest chunk from profits.
- refurb 10y agopromotion and advertising that take the biggest chunk from profits Are you saying that if a drug company didn't promote or advertise their profits would go up? That makes no sense at all. Why would a drug company spend money on promotion and advertising unless they got a positive return from it.
- mirimir 10y agoWell, without promotion and advertising, they arguably would not have very much profit. But "take the biggest chunk from profits" wasn't clear. What I meant is that promotion and advertising comprise a substantially larger share of revenue than research and development do.